A uniform pricing regime ignores the heterogeneity within the pharma sector Kalyani Sharma May 15, 2026 Dr Amit Kumar: How can policy frameworks better align commercial interests in the pharma sector with broader public health goals?…
Top of ANDA approvals list, low on IP index Viveka Roychowdhury Mar 7, 2023 India's dominance of ANDA approvals juxtaposed with the continued low ranking in the US Chamber of Commerce’s International IP…
